Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
About this item
Full title
Author / Creator
Publisher
Boston: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Among more than 1.7 million persons, BNT162b2 vaccination was associated with increased risks of myocarditis (risk ratio, 3.24), lymphadenopathy, appendicitis, and herpes zoster infection; in comparison, Covid-19 increased the risks of myocarditis (risk ratio, 18.28), pericarditis, arrhythmia, deep-vein thrombosis, pulmonary embolism, myocardial in...
Alternative Titles
Full title
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8427535
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8427535
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2110475
